Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

395 ARTÍCULOS , VIENDO DEL 316 AL 330

[Early diagnosis of Alzheimer's disease (with the announcement of the diagnosis)]

Ivanoiu A, Engelborghs S, Hanseeuw B.

Rev Prat. 2020 Feb;70(2):158-163.

A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group

O'Gorman C, Khoury R, Anderson A, Carter M, DiCesare F, Dubé S, Ereshefsky L, Grossberg G, Hefting N, Khan S, Lind S, Moebius H, Shiovitz T, Rosenberg P.

J Prev Alzheimers Dis. 2020;7(4):274-282. doi: 10.14283/jpad.2020.37.

Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research

Blazel MM, Lazar KK, Van Hulle CA, Ma Y, Cole A, Spalitta A, Davenport-Sis N, Bendlin BB, Wahoske M, Illingworth C, Gleason CE, Edwards DF, Blazel H, Asthana S, Johnson SC, Carlsson CM.

J Alzheimers Dis. 2020;77(4):1559-1567. doi: 10.3233/JAD-200394.

Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps

Badji A, Westman E.

Psychiatry Res Neuroimaging. 2020 Dec 30;306:111184. doi: 10.1016/j.pscychresns.2020.111184. Epub 2020 Sep 7.

Cortisol hypersecretion and the risk of Alzheimer's disease: A systematic review and meta-analysis

Zheng B, Tal R, Yang Z, Middleton L, Udeh-Momoh C.

Ageing Res Rev. 2020 Dec;64:101171. doi: 10.1016/j.arr.2020.101171. Epub 2020 Sep 22.

Alzheimer disease biomarker profiles in dementia with Lewy bodies: Does A plus T spell D-L-B?

Koyama AK, Irwin DJ.

Neurology. 2020 Dec 15;95(24):1076-1077. doi: 10.1212/WNL.0000000000010958. Epub 2020 Sep 28.

Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis

Czakó C, Kovács T, Ungvari Z, Csiszar A, Yabluchanskiy A, Conley S, Csipo T, Lipecz A, Horváth H, Sándor GL, István L, Logan T, Nagy ZZ, Kovács I.

Geroscience. 2020 Dec;42(6):1499-1525. doi: 10.1007/s11357-020-00252-7. Epub 2020 Oct 4.

CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment

Gaetani L, Paolini Paoletti F, Bellomo G, Mancini A, Simoni S, Di Filippo M, Parnetti L.

Trends Pharmacol Sci. 2020 Dec;41(12):1023-1037. doi: 10.1016/j.tips.2020.09.011. Epub 2020 Oct 27.

Applications of iTRAQ and TMT Labeling Techniques to the Study of Neurodegenerative Diseases

Li K, Chen Z, Zhang Y, Yang X.

Curr Protein Pept Sci. 2020;21(12):1202-1217. doi: 10.2174/1389203721666201103085704.

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease

Arastoo M, Lofthouse R, Penny LK, Harrington CR, Porter A, Wischik CM, Palliyil S.

Int J Mol Sci. 2020 Nov 17;21(22):8673. doi: 10.3390/ijms21228673.

[Analysis of cerebrospinal fluid in the diagnosis of cognitive impairment and dementia]

Frederiksen KS, Hasselbalch S, Waldemar G.

Ugeskr Laeger. 2020 Nov 2;182(45):V05200352.

Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia

Funnell C, Feldman HH, Mackenzie IRA, DeMarco ML.

Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):357-359. doi: 10.1097/WAD.0000000000000372.

Comprehensive Review on Alzheimer's Disease: Causes and Treatment

Breijyeh Z, Karaman R.

Molecules. 2020 Dec 8;25(24):5789. doi: 10.3390/molecules25245789.

Inflammatory Biomarkers in AD: Implications for Diagnosis

Kim J, Kim YK.

Curr Alzheimer Res. 2020;17(11):962-971. doi: 10.2174/1567205017666201223152612.

Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging

Bilgel M, Beason-Held L, An Y, Zhou Y, Wong DF, Resnick SM.

J Cereb Blood Flow Metab. 2020 Feb;40(2):288-297. doi: 10.1177/0271678X19830537. Epub 2019 Feb 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias